Pacific Biosciences of California (PACB) PT Lowered to $1.75 at Goldman Sachs

January 23, 2025 6:09 AM EST Send to a Friend

Goldman Sachs analyst Matthew Sykes lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Pacific Biosciences of California (PACB) PT Lowered to $1.75 at Goldman Sachs

Member Login

Free News Feed